Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine?

Bradford D. Gessner, Darryn L. Knobel, Anne Conan, Adam Finn

Research output: Contribution to journalArticle (Academic Journal)

15 Citations (Scopus)

Abstract

The RTS,S/AS01 malaria vaccine has been associated with meningitis and cerebral malaria safety signals. Key characteristics of the meningitis signal include presence, in the 5–17 month but not the 6–12 week age group, of delayed and variable meningitis onset after vaccination, and multiple etiologies. For both meningitis and cerebral malaria, the 5–17 month old age group control arm had abnormally low incidences while other arms in both age groups had meningitis and cerebral malaria incidences similar to background rates. No single hypothesis postulating an adverse effect from RTS,S/AS01 unites these observations. Unlike the 6–12 week group, the control population in the 5–17 month old age group received rabies vaccine. This raises the possibility that non-specific rabies vaccine effects had a protective effect against central nervous system infection, a hypothesis consistent with the epidemiologic data. The lack of a confirmed biologic mechanism for such an effect emphasizes the need for additional studies.
Original languageEnglish
Pages (from-to)716–721
Number of pages6
JournalVaccine
Volume35
Issue number5
Early online date5 Jan 2017
DOIs
Publication statusPublished - 1 Feb 2017

Keywords

  • Adverse events
  • Central nervous system infection
  • Immunization
  • Malaria
  • Meningitis
  • Non-specific effects
  • Rabies
  • Safety
  • Vaccine

Fingerprint Dive into the research topics of 'Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine?'. Together they form a unique fingerprint.

Cite this